Skip to main content
Signal8

Gross Jane A

SEC insider (Form 3/4/5 filer). CIK 0001684258. Director at aTYR PHARMA INC (ATYR). 3 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in SAN DIEGO, CA.

Companies Gross Jane A has filed insider reports for

  • aTYR PHARMA INC (ATYR): Director
Gross Jane A profile photo

Gross Jane A

CIK: 0001684258

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

aTYR PHARMA INC logo
ATYR

aTYR PHARMA INC

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • aTYR PHARMA INC logo
    ATYR

    aTYR PHARMA INC

    May 11, 2026
    Award

    Stock Option (right to buy)

    Direct
    50K shares-
  • aTYR PHARMA INC logo
    ATYR

    aTYR PHARMA INC

    May 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    50K shares-
  • aTYR PHARMA INC logo
    ATYR

    aTYR PHARMA INC

    Mar 17, 2025
    Purchase
    Direct
    3.8K shares at avg. $4.00$15K

1-3 of 3